Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchMetforminMetformin (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Metformin reduces the risk of Long COVID or Death over 6 months in an Emulated Target Trial of Primarily Omicron-infected Adults without Diabetes or Prediabetes: a New-User, Active-Comparator Analysis Using the National COVID Cohort Collaborative (N3C) Electronic Health Record Database. This research was supported in part by the Intramural/Extramural research program of the National Center for Advancing Translational Science, NIH

Bramante et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofae631.016
Jan 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
PASC or death 53% Improvement Relative Risk Metformin  Bramante et al.  EARLY TREATMENT Is early treatment with metformin beneficial for COVID-19? Retrospective 496 patients in the USA Lower PASC with metformin (p=0.021) c19early.org Bramante et al., Open Forum Infectious.., Jan 2025 Favorsmetformin Favorscontrol 0 0.5 1 1.5 2+
Metformin for COVID-19
3rd treatment shown to reduce risk in July 2020, now with p < 0.00000000001 from 103 studies.
No treatment is 100% effective. Protocols combine treatments.
5,300+ studies for 115 treatments. c19early.org
Emulated target trial of Omicron-infected outpatients without diabetes or prediabetes, showing significantly lower long COVID or death with metformin treatment.
PASC or death, 53.0% lower, HR 0.47, p = 0.02, treatment 10 of 248 (4.0%), control 21 of 248 (8.5%), NNT 23.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Bramante et al., 29 Jan 2025, retrospective, USA, peer-reviewed, 10 authors.
This PaperMetforminAll
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit